Jurjen Versluis
@JurjenVersluis
Followers
70
Following
36
Statuses
23
RT @DelwelRuud: Erasmus Hematology Virtual Lecture! 02 December 2024 at 16.00 CET we have Elsa Bernard (@Elsa2Bernard), Gustave Roussy in V…
0
14
0
RT @pvyas_oxford: Really pleased to share this clinically important collaborative study between UK AmML Clinical Trial Group and Hovon. The…
0
3
0
Read the full study: Special thanks to @pvyas_oxford and Peter Valk for leading this great UK-HOVON joint project. Many thanks to all collaborators to these clinical trials! #HOVON #NCRI. 🧵9/9
0
0
3
External (Real-world) Control Data are increasingly being used in Hem/Onc research. But do they live up to expectations? Check out this important review by @niek_maas and @sjfhermans, now in @JAMAOnc!
New paper out in @JAMAOnc! 🚨 Real-world data (RWD) external control arms are gaining traction in prospective studies, but we need to balance their advantages with meeting evidentiary standards Our review highlights significant differences between RWD and trial data🧵(1/7)
0
0
7
Thank you so much for hosting and having us at this great congress in Cape Town! @clinicalhaemat1
Sasmo-Sascets 2024! We have been blessed with awesome speakers; mentors ; friends - we are immensely grateful! @DrLornan @CarmemBonfim1 @AnnaSureda5 @CarmeloGurnari @JurjenVersluis
0
0
4
Important work on innovative trial approaches for patients with hematological malignancies! Great work @niek_maas!
I'm really pleased to share our latest manuscript in @BloodCancerJnl: Bayesian analysis might be considered to expedite clinical trial adaptation and enhance efficiency in drug development. Thanks to all collaborators! @JurjenVersluis #HOVON #Bayesian
0
0
0
RT @Dr_AmerZeidan: Important alert to all transplanters! Every #TransplantAllogeneic Doc who sees #MDSsm patients should read this paper by…
0
58
0
Fantastic talk by @niek_maas: a novel prognostic model for patients with AML in first relapse. Very proud mentor! #ash23 #hovon
2
3
11
Very proud of @sjfhermans presenting his work on external control data for clinical trials. Check out the poster tonight #ASH23 @HarmonynetEU @ADinmohamed
Want to learn more about potential use of @HarmonynetEU external control data in clinical trials for elderly AML? Let's chat tonight 6-8PM at poster 2854 #ASH2023 Abstract:
0
2
8
RT @DelwelRuud: September 18th, we will continue the Erasmus Virtual Hematology Lecture series with Kathrin Bernt. We will continue the 202…
0
33
0
📣Join us NOW! Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups FREE REGISTRATION @JurjenVersluis @nagler_EBMT @Mohty_EBMT
0
0
5